MEN1 and multiple endocrine neoplasia: MEN4 (also described as “MEN1 mimicker”) [133], underlying CDKN1B (cyclin-dependent kinase inhibitor) germline pathogenic variants represent the rarest MEN type (an incidence of less than one individual per million-person) [134,135].